Outcomes of Smoker and Drinker With Esophageal Squamous Cell Carcinoma After Esophagectomy
OSinEC
Long-term Outcomes of Smoker and Drinker With Esophageal Squamous Cell Carcinoma After Esophagectomy
1 other identifier
observational
2,957
1 country
1
Brief Summary
Our study demonstrates that patients who did not consume alcohol or smoke had a significant advantage in overall survival (OS) after undergoing esophagectomy. Furthermore, our findings indicate that there was no statistically significant difference in OS between patients with a history of both smoking and drinking, and those who only smoked or drank
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 12, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedFebruary 21, 2024
February 1, 2024
14.5 years
February 12, 2024
February 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Survival
Overall Survival was calculated from the month and year of surgery to the time of death or last follow-up in April 2024
April 2022-April 2024
Study Arms (2)
high-risk
Smoker and Drinker with Esophageal Squamous Cell Carcinoma after Esophagectomy
low-risk
Non-Smoker and Non-Drinker with Esophageal Squamous Cell Carcinoma after Esophagectomy
Interventions
Eligibility Criteria
patients with esophageal cancer
You may qualify if:
- patients with esophageal cancer
You may not qualify if:
- (1) pathology confirmed a non-squamous cell carcinoma, (2) the tumor was located outside of the thoracic region, (3) R1/R2 resection was performed indicating incomplete tumor removal, (4) evidence of distant tumor metastasis was observed, (5) they underwent preoperative neoadjuvant therapy, (6) pTis/T1a stage (7) Missing data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sichuan Cancer Hospital and Research Institute
Chengdu, Sichuan, 610041, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 12, 2024
First Posted
February 21, 2024
Study Start
February 1, 2010
Primary Completion
July 30, 2024
Study Completion
August 30, 2024
Last Updated
February 21, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share